The expression of AIB1 correlates with cellular proliferation in human prolactinomas

Annals of Anatomy

Volumn 195, Issue 3, 2013, Pages 253-259

  Carretero, José ^a,b   Blanco, Enrique J ^a,b   Carretero, Manuel ^c   Carretero Hernández, Marta ^a   García Barrado, M José ^a,b   Iglesias Osma, M Carmen ^a,b   Burks, Deborah Jane ^d   Font de Mora, Jaime ^d  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c UNIVERSIDAD PONTIFICIA DE SALAMANCA   (Spain)

^d CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

AIB1; Aromatase; Cell cycle; Estrogen; Pituitary; Prolactinomas

Indexed keywords

AROMATASE; CASPASE 3; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; PROLACTIN; STEROID RECEPTOR COACTIVATOR 3;

APOPTOSIS; ARTICLE; CELL CYCLE PHASE; CELL POPULATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPROLACTINEMIA; HYPOPHYSIS TUMOR; NUCLEOTIDE SEQUENCE; PROLACTINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; TUMOR CELL;

CELL PROLIFERATION; FEMALE; HUMANS; NUCLEAR RECEPTOR COACTIVATOR 3; PITUITARY NEOPLASMS; PROLACTINOMA; RECEPTORS, ESTROGEN; STATISTICS AS TOPIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84876729479     PISSN: 09409602     EISSN: 16180402     Source Type: Journal    
DOI: 10.1016/j.aanat.2013.01.009     Document Type: Article

References (55)

1. Akinci H., Kapucu A., Dar A.K.A., Celik O., Tutunculer B., Sirin G., Oz B., Gazioglu N., Ince H., Aliustaoglu S., Kadioglu P. Aromatase cytochrome P540 enzyme expression in prolactinomas and its relationship to tumor behavior. Pituitary 2012, 10.1007/s11102-012-0436-2.
2. Amazit L., Pasini L., Szafran A.T., Berno V., Wu R.C., Mielke M., Jones E.D., Mancini M.G., Hinojos C.A., O'Malley B.W., Mancini M.A. Regulation of SRC-3 intercompartmental dynamics by estrogen receptor and phosporylation. Mol. Cell. Biol. 2007, 27:6913-6932.
3. Anzick S.L., Kononen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.Y., Sauter G., Kallioniemi O.P., Trent J.M., Meltzer P.S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997, 277:965-968.
4. Carretero J., Blanco E., Vázquez G., Rubio M., Santos M., Pérez R.M., Vázquez R. Immunohistochemical evidence for the expression of aromatase P450 in the rat hypophysis. Cell Tissue Res. 1999, 295:419-423.
5. Carretero J., Vázquez G., Martín-Clavijo A., Rubio M., Hernández E., Moro J.A., Gato A., Barbosa E., Vázquez R. In vivo studies on cytodifferentiation of pituitary aromatase-immunoreactive cells. Eur. J. Anat. 1999, 3:79-85.
6. Carretero J., Burks D.J., Vazquez G., Rubio M., Hernandez E., Bodego P., Vazquez R. Expression of aromatase P450 is increased in spontaneous prolactinomas of aged rats. Pituitary 2002, 5:5-10.
7. Carretero J., Vázquez G., Rubio M., Blanco E., Juanes J.A., Pérez E., Burks D.J., Vázquez R. Postnatal differentiation of the immunohistochemical expresion of aromatase P450 in the rat pituitary gland. Histol. Histopathol. 2003, 18:419-423.
8. Carretero J., Blanco E., Rubio M., Riesco J.M., García-Barrado M.J., Iglesias-Osma M.C., Carretero-Hernández M., Herrero J.J., Burks D.J. Gonadal steroids regulate aromatase P450 expression in the rat pituitary. Eur. J. Anat. 2011, 15:98-106.
9. Chaidarun S.S., Swearingen B., Alexander J.M. Differential expression of estrogen receptor-beta (ER beta) in human pituitary tumors: functional interactions with ER alpha and a tumor-specific splice variant. J. Clin. Endocrinol. Metab. 1998, 83:3308-3315.
10. Chen S., Shively J.E., Nakajin S., Shinoda M., Hall P.F. Amino terminal sequence analysis of human placenta aromatase. Biochem. Biophys. Res. Commun. 1986, 135:713-719.
11. Chien C.D., Kirilyuk A., Li J.V., Zhang W., Lahusen T., Schmidt M.O., Oh A.S., Wellstein A., Riegel A.T. Role of the nuclear receptor coactivator AIB1-Δ4 splice variant in the control of gene transcription. J. Biol. Chem. 2011, 286:26813-26827.
12. Ferrero M., Avivar A., García-Macías M.C., Font de Mora J. Phosphoinositide 3-kinase/Akt signaling can promote AIB1 stability independently of GSK3 phosphorylation. Cancer Res. 2008, 68:5450-5459.
13. Font de Mora J., Brown M. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol. Cell. Biol. 2000, 20:5041-5047.
14. Galmiche G., Corvaisier S., Kottler M.L. Aromatase gene expression and regulation in the female rat pituitary. Ann. N. Y. Acad. Sci. 2006, 1070:286-292.
15. Galmiche G., Richard N., Corvaisier S., Kottler M.L. The expression of aromatase in gonadotropes is regulated by estradiol and gonadotropin-releasing hormone in a manner that differs from the regulation of luteinizing hormone. Endocrinology 2006, 147:4234-4244.
16. Garabedian M.J., Logan S.K. Atypical regulation of SRC-3. Trends Biochem. Sci. 2008, 33:301-304.
17. Ghadimi B.M., Schrock E., Walker R.L., Wangsa D., Jauho A., Meltzer P.S., Ried T. Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. Am. J. Pathol. 1999, 154:525-536.
18. Gnanapragasam V.J., Leung H.Y., Pulimood A.S., Neal D.E., Robson C.N. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer. Br. J. Cancer 2001, 85:1928-1936.
19. Gooren L.J., Assies J., Asscheman H., de Slegte R., van Kessel H. Estrogen-induced prolactinoma in a man. J. Clin. Endocrinol. Metab. 1988, 66:444-446.
20. Harada N., Sasano H., Murakami H., Onkuma T., Nagura H., Takagi Y. Localized expression of aromatase in human vascular tissues. Circ. Res. 1999, 84:1285-1291.
21. Harada N. Cloning of a complete cDNA encoding human aromatase: immunochemical identification and sequence analysis. Biochem. Biophys. Res. Commun. 1988, 156:725-732.
22. Heaney A.P., Fernando M., Melmed S. Functional role of estrogen in pituitary tumor pathogenesis. J. Clin. Invest. 2002, 109:277-283.
23. Henke R.T., Haddad B.R., Kim S.E., Rone J.D., Mani A., Jessup J.M., Wellstein A., Maitra A., Riegel A.T. Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma. Clin. Cancer Res. 2004, 10:6134-6142.
24. Hudelist G., Czerwenka K., Kubista E., Marton E., Pischinger K., Singer C.F. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific coactivator. Breast Cancer Res. Treat. 2003, 78:193-204.
25. Kadioglu P., Oral G., Sayitoglu M., Erensoy N., Senel B., Gazioglu N., Sav A., Cetin G., Ozbek U. Aromatase cytochrome P450 enzyme expression in human pituitary. Pituitary 2008, 11:29-35.
26. Kefalopoulou Z., Tzelepi V., Zolota V., Grivas P.D., Christopoulos C., Kalofonos H., Maraziotis T., Sotiropoulou-Bonikou G. Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis. J. Neurooncol. 2012, 106:23-31.
27. Kuang S.Q., Liao L., Zhang H., Lee A.V., O'Malley B.W., Xu J. AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice. Cancer Res. 2004, 64:1875-1885.
28. Kurebayashi J., Otsuki T., Kunisue H., Tanaka K., Yamamoto S., Sonoo H. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer. Clin. Cancer Res. 2000, 6:512-518.
29. Leo C., Chen J.D. The SRC family of nuclear receptor coactivators. Gene 2000, 245:1-11.
30. Lloyd H.M., Meares J.D., Jacobi J. Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells. Nature 1975, 255:497-498.
31. Louie M.C., Zou J.X., Rabinovich A., Chen H.W. ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol. Cell. Biol. 2004, 24:5157-5171.
32. Misiti S., Schomburg L., Yen P.M., Chin W.W. Expression and hormonal regulation of coactivator and corepressor genes. Endocrinology 1998, 139:2493-2500.
33. Molitch M. Prolactinomas. Prolactin 2001, 82-99. Kluwer Academic Publishers, Boston, MA, USA. N. Horseman (Ed.).
34. Nagy L., Kao H.Y., Love J.D., Li C., Banayo E., Gooch J.T., Krishna V., Chatterjee K., Evans R.M., Schwabe J.W. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 1999, 13:3209-3216.
35. Nakles R.E., Shiffert M.T., Díaz-Cruz E.S., Cabrera M.C., Alotaiby M., Miermont A.M., Riegel A.T., Furth P.A. Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content. Mol. Endocrinol. 2011, 25:549-563.
36. Osborne C.K., Bardou V., Hopp T.A., Chamness G.C., Hilsenbeck S.G., Fuqua S.A., Wong J., Allred D.C., Clark G.M., Schiff R. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J. Natl. Cancer Inst. 2003, 95:353-361.
37. Paramanik V., Thakur M.K. AIB1 shows variation in interaction with ERβTAD and expression as a function of age in mouse brain. Biogerontology 2011, 12:321-328.
38. Perez R.L., Machiavelli G.A., Romano M.I., Burdman J.A. Prolactin release, oestrogens and proliferation of prolactin-secreting cells in the anterior pituitary gland of adult male rats. J. Endocrinol. 1986, 108:399-403.
39. Phelps C., Hymer W.C. Characterization of estrogen-induced adenohypophyseal tumors in the Fischer 344 rat. Neuroendocrinology 1983, 37:23-31.
40. Planas-Silva M.D., Shang Y., Donaher J.L., Brown M., Weinberg R.A. AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Cancer Res. 2001, 61:3858-3862.
41. Sakakura C., Hagiwara A., Yasuoka R., Fujita Y., Nakanishi M., Masuda K., Kimura A., Nakamura Y., Inazawa J., Abe T., Yamagishi H. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int. J. Cancer 2000, 89:217-223.
42. Shang Y., Hu X., DiRenzo J., Lazar M.A., Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000, 103:843-852.
43. Shupnik M.A., Pitt L.K., Soh A.Y., Anderson A., Lopes M.B., Laws E.R. Selective expression of estrogen receptor a and b isoforms in human pituitary tumors. J. Clin. Endocrinol. Metab. 1998, 83:3965-3972.
44. Stefaneanu L., Kovacs K., Horvath E., Lloyd R.V., Buchfelder M., Fahlbusch R., Smyth H. In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas. J. Clin. Endocrinol. Metab. 1994, 78:83-88.
45. Suen C.S., Berrodin T.J., Mastroeni R., Cheskis B.J., Lyttle C.R., Frail D.E. A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity. J. Biol. Chem. 1998, 273:27645-27653.
46. Tikkanen M.K., Carter D.J., Harris A.M., Le H.M., Azorsa D.O., Meltzer P.S., Murdoch F.E. Endogenously expressed estrogen receptor and coactivator AIB1 interact in MCF-7 human breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:12536-12540.
47. Tilli M.A., Reiter R., Oh A.S., Henke R.T., McDonnell K., Gallicano G.I., Furth P.A., Riegel A.T. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice. Mol. Endocrinol. 2005, 19:644-656.
48. Torres-Arzayus M.I., Font de Mora J., Yuan J., Vazquez F., Bronson R., Rue M., Sellers W.R., Brown M. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 2004, 6:263-274.
49. Wang Z., Rose D.W., Hermanson O., Liu F., Herman T., Wu W., Szeto D., Glieberman A., Krones A., Pratt K., Rosenfeld R., Glass C.K., Rosenfeld M.G. Regulation of somatic growth by the p160 coactivator p/CIP. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:13549-13554.
50. Wang Y., Wu M.C., Sham J.S., Zhang W., Wu W.Q., Guan X.Y. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer 2002, 95:2346-2352.
51. Wingrave S.J., Kay C.R., Vessey M.P. Oral contraceptives and pituitary adenomas. Br. Med. J. 1980, 280:685-686.
52. Xie D., Sham J.S., Zeng W.F., Lin H.L., Bi J., Che L.H., Hu L., Zeng Y.X., Guan X.Y. Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma. Hum. Pathol. 2005, 36:777-783.
53. Xu J., Liao L., Ning G., Yoshida-Komiya H., Deng C., O'Malley B.W. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:6379-6384.
54. Zhang H., Liao L., Kuang S.Q., Xu J. Spatial distribution of the messenger ribonucleic acid and protein of the nuclear receptor coactivator, amplified in breast cancer-3, in mice. Endocrinology 2003, 144:1435-1443.
55. Zhou G., Hashimoto Y., Kwak I., Tsai S.Y., Tsai M.J. Role of the steroid receptor coactivator SRC-3 in cell growth. Mol. Cell. Biol. 2003, 23:7742-7755.